Shares of Spire Healthcare Group plc (LON:SPI - Get Free Report) hit a new 52-week high during trading on Monday . The stock traded as high as GBX 321.71 ($4.07) and last traded at GBX 321.71 ($4.07), with a volume of 607611 shares changing hands. The stock had previously closed at GBX 234 ($2.96).
Analyst Ratings Changes
A number of analysts recently commented on SPI shares. Berenberg Bank reaffirmed a "buy" rating and set a GBX 286 ($3.62) price target on shares of Spire Healthcare Group in a research report on Thursday, February 29th. JPMorgan Chase & Co. reaffirmed an "overweight" rating and set a GBX 295 ($3.73) target price on shares of Spire Healthcare Group in a research report on Monday, February 26th.
Read Our Latest Research Report on SPI
Spire Healthcare Group Stock Performance
The business has a 50 day moving average of GBX 235.51 and a 200-day moving average of GBX 227.84. The company has a market capitalization of £949.71 million, a P/E ratio of 4,595.86, a price-to-earnings-growth ratio of 1.06 and a beta of 0.99. The company has a debt-to-equity ratio of 170.37, a quick ratio of 0.74 and a current ratio of 0.69.
Spire Healthcare Group Increases Dividend
The company also recently declared a dividend, which will be paid on Friday, June 21st. Stockholders of record on Thursday, May 23rd will be given a dividend of GBX 2.10 ($0.03) per share. This is a positive change from Spire Healthcare Group's previous dividend of $0.50. This represents a dividend yield of 0.89%. The ex-dividend date is Thursday, May 23rd. Spire Healthcare Group's payout ratio is 4,285.71%.
About Spire Healthcare Group
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Featured Stories
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
